Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




NeurogesX Wins Big Approval – Analyst Blog

Zacks Market Commentaries (November 17th, 2009) Writes:
FDA Approves NeurogesX's Qutenza After the market closed on November 16, 2009, NeurogesX (NGSX) announced that the U.S. FDA had approved Qutenza (capsaicin patch) for the management of neuropathic pain due to postherpetic neuralgia (PHN).  We expect management to spend the next several months preparing for the launch by facilitating reimbursement procedure, establishing distribution channels, hiring and training the specialty sales force, and conducting the manufacturing for commercial supply. Key to our bullish sales forecast for the drug will be establishing a permanent reimbursement code for both the product and application, as Qutenza requires administration by a physician or healthcare professional. Qutenza is a cutaneous (skin) patch designed to treat peripheral neuropathic pain conditions. The Qutenza patch provides a pure high concentration (8%) of a synthetic capsaicin, known as trans­-capsaicin, directly to the site of pain via a rapid-delivery cutaneous delivery system designed to provide ...

Zacks Analyst Blog Highlights: Apple Inc., Microsoft Corp, Quality Systems Inc., Allscripts-Misys Healthcare Solutions, Inc. and Cerner Corp. – Press Releases

Zacks Market Commentaries (November 16th, 2009) Writes:

For Immediate Release

Chicago, IL – November 16, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (AAPL), Microsoft Corp (MSFT), Quality Systems Inc. (QSII), Allscripts-Misys Healthcare Solutions, Inc. (MDRX) and Cerner Corp. (CERN).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Friday’s Analyst Blog:

Apple Opens New Store in New York

Apple Inc. (AAPL) will open its newest retail store with an 8,500 square feet retail space in New York tomorrow. The store will help Apple deliver more Macs, iPods and iPhones, taking advantage of the coming holiday

...

Quality Systems Barely Beats – Analyst Blog

Zacks Market Commentaries (November 13th, 2009) Writes:
Quality Systems Inc. (QSII) reported fiscal second-quarter earnings of 41 cents, beating the Zacks Consensus Estimate by a penny and the year-ago earnings by 4 cents.   Total revenues for the quarter increased 21.5% to $71.69 million from $58.98 million. The company’s NextGen Healthcare Information Systems division posted revenue of $67.4 million for the reported quarter, representing a 23% increase from the previous year.   Category-wise, System sales, including software, hardware and supplies, increased 5.9% to $26.24 million from $24.78 million. Revenues from maintenance, electronic data interchange (EDI), revenue cycle management (RCM) and other services grew 32.9% to $45.46 million from $34.19 million in the year-ago period.   The total cost of system sales, including software, hardware and supplies increased 16.8% to $7 million. Total cost of maintenance, EDI, RCM and other services for the quarter were $21.27 million as against $15.2 million in the year-ago quarter, up ...

Medtronic Reports Trial Enrollment – Analyst Blog

Zacks Market Commentaries (November 12th, 2009) Writes:
Medtronic Inc. (MDT) recently reported the first enrollment for its Attain Success trial. The trial evaluates implant success, complication rates and procedure times for the company’s Attain Family of left-heart leads and delivery systems portfolio which are already available in the market.  The Attain Success trial enrollment will have roughly 2,000 patients at 150 medical centers in 18 countries around the world. The company will analyze data at baseline, implant and three months post-implant. The study will also capture implant success and complication rates (up to three months), procedure times, handling feedback and physician survey data.  In addition, the Attain Success trial enrollment will have a sub-study that will assess final left-heart lead placement site. Patients enrolled in the test will have a cardiac resynchronization therapy-defibrillator (CRT) device implanted in them. Results from the test are expected in 30 months.  If successful, the Attain Success ...

Qualsec’s Wholly-Owned Subsidiary Receives Order From New Jersey-Based DMC Athletics and Rehabilitation

Stuart Smith (November 5th, 2009) Writes:

WAYNE, Pa., Nov. 5 /PRNewswire-FirstCall/ — Qualsec’s (OTC Bulletin Board: QLSZ)(German WKN: A0YCND) wholly-owned subsidiary, VitaminSpice, has received an order from DMC Athletics & Rehabilitation. This multi-facility physical therapy and personal training business will offer products of QLSZ’s wholly-owned subsidiary, VitaminSpice, on their website and at their centers providing dietary support to their various wellness programs. DMC and VitaminSpice have plans to co-develop e-commerce products in the nutraceutical, foodceutical, and vitamin-enhanced commodity-foods markets.

The number-one rated physical therapy and wellness centers as voted by the Readers Choice for the past 4 years, DMC Athletics and Rehabilitation is a private, outpatient orthopedic facility providing treatment of all orthopedic and sports injuries and everyday physical discomforts, as well as personal training and exercise regimens for preventive care. DMC plans to expand VitaminSpice distribution to and through its affiliated medical centers and bariatric, nutritionists, cardiac and other physician groups

DMC offers personal training

...

BMTS Announces the Introduction of the Demolizer II System Into the Geisinger Health System

Stuart Smith (November 4th, 2009) Writes:

ENGLEWOOD, CO — (Marketwire) — 11/04/09 — Biomedical Technology Solutions Holdings, Inc. (”BMTS” or the “Company”; www.bmtscorp.com) (OTCBB: BMTL) is pleased to announce the introduction of the Demolizer® II System into the Geisinger Health organization for the onsite treatment of biomedical waste.

The Geisinger Health System is one of the nation’s leading fully integrated health services organizations. Founded in 1915, Geisinger is a physician-led health care system, dedicated to health care, education, research and service spanning 43 counties in Pennsylvania and serving over 2.6 million people in primarily rural communities.

The Demolizer® II is a safe and simple biomedical waste treatment system ideally suited to meet the unique needs of clinics in rural areas where the cost, both financial and environmental, of traditional transport and offsite disposal can be prohibitive. Cost savings from adoption of the Demolizer® II are expected to be significant. More importantly, the Demolizer® II

...

ProAssurance Outperforms – Analyst Blog

Zacks Market Commentaries (November 3rd, 2009) Writes:
ProAssurance Corp.’s (PRA) third-quarter operating earnings of $1.58 per share was substantially ahead of the Zacks Consensus Estimate of $1.23. This also compares favorably with the earnings of $1.31 per share in the prior-year quarter.   The company’s earnings benefitted from a 54.6% year-over-year growth in revenues, primarily due to recent acquisitions. However, the better-than-expected top-line was partly offset by a 13.5% increase in total expenses.   Net income in the quarter was $55.2 million or $1.67 per share, compared to $22.2 million or 66 cents per share in the prior-year quarter.   Gross written premiums during the quarter increased 33.6% year over year to $168.6 million. The PICA Group, which writes approximately 50% of ProAssurance’s business in the third quarter, accounted for $43.1 million of new business. The improvement in income from investments in unconsolidated subsidiaries was principally driven by improved market conditions.   Net ...

Zacks Analyst Blog Highlights: Allscripts-Misys Healthcare Solutions, Inc., Intuit Inc., Cerner Corporation, Quality Systems Inc. and MedAssets Inc. – Press Releases

Zacks Market Commentaries (October 14th, 2009) Writes:

For Immediate Release

Chicago, IL – October 14, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Allscripts-Misys Healthcare Solutions, Inc. (MDRX), Intuit Inc. (INTU), Cerner Corporation (CERN), Quality Systems Inc. (QSII) and MedAssets Inc. (MDAS).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Tuesday’s Analyst Blog:

Allscripts Aligns with Quicken

Allscripts-Misys Healthcare Solutions, Inc. (MDRX) recently entered in an alliance with Intuit Inc. (INTU), a leading provider of business and financial management solutions, to offer Quicken Health Bill Pay.

This is the first online service that integrates with

...

Allscripts Aligns with Quicken – Analyst Blog

Zacks Market Commentaries (October 13th, 2009) Writes:
Allscripts-Misys Healthcare Solutions, Inc. (MDRX) recently entered in an alliance with Intuit Inc. (INTU), a leading provider of business and financial management solutions, to offer Quicken Health Bill Pay. This is the first online service that integrates with Allscripts' practice management and revenue cycle management solutions. As the name indicates, the system helps explain patients their medical bills and enable them to pay online while helping physicians get paid faster. Quicken Health Bill Pay alerts patients more quickly that a payment is due. The system displays how the amount due was calculated in simple mathematics and provides accurate data. The system quickens the patient bill payment process by an average of 18 days compared to the traditional way of using paper check. It also reduces the cost of collection incurred in the traditional process. It’s been observed that many physician practices write off roughly ...

Virtual Health Technologies, Inc. (VHGI.OB) Licenses Cifra Platform to Wound Care Innovations

QualityStocks (October 12th, 2009) Writes:

Today, VirtualHealth Technologies, Inc., provider of electronic health records security technology, announced that its subsidiary, Secure eHealth, has entered into an agreement with a subsidiary of Wound Management Technologies Inc, Wound Care Innovations, LLC. The agreement allows Wound Care the use of Secure eHealth’s Cifra secure healthcare platform. WCI will use the highly secure messaging system to work with its CellerateRx® products.

Wound Care Innovations will initially focus on using the Cifra platform to exchange secure messages, to transport files with the secure document courier and to store related documents. In the second phase, the Secure eHealth System Tray Notifier technology will be added to send secure notification alerts to enrolled users. The companies plan to offer the integrated system to Wound Care Innovations’ vendors, partners and health care community associates.

Jim Renfro, President of VirtualHealth Technologies, commented, “We are excited to have Wound Care Innovations license our security platform for their

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.